(Updated - July 6, 2021 7:41 AM EDT)

Citi analyst Yigel Nochomovitz upgraded ORIC Pharamceuticals (NASDAQ: ORIC) from Neutral ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE